ACA, an inhibitor phospholipases A2 and transient receptor potential melastatin-2 channels, attenuates okadaic acid induced neurodegeneration in rats
dc.authorid | Yologlu, Saim/0000-0002-9619-3462 | |
dc.authorid | Cigremis, Yilmaz/0000-0002-8600-0946 | |
dc.authorid | Cakir, Murat/0000-0002-2066-829X | |
dc.authorid | Taslidere, Elif/0000-0003-1723-2556 | |
dc.authorid | Tekin, Suat/0000-0002-2757-1802; | |
dc.authorwosid | Yologlu, Saim/ABI-8014-2020 | |
dc.authorwosid | Cigremis, Yilmaz/JAC-8451-2023 | |
dc.authorwosid | Cigremis, Yilmaz/O-6019-2015 | |
dc.authorwosid | Cakir, Murat/I-8643-2019 | |
dc.authorwosid | Tekin, Suat/AAG-1440-2021 | |
dc.authorwosid | Taslidere, Elif/ABI-8046-2020 | |
dc.authorwosid | Özgöçer, Tuba/AAA-1751-2021 | |
dc.contributor.author | Cakir, Murat | |
dc.contributor.author | Duzova, Halil | |
dc.contributor.author | Tekin, Suat | |
dc.contributor.author | Taslidere, Elif | |
dc.contributor.author | Kaya, Gul Busra | |
dc.contributor.author | Cigremis, Yilmaz | |
dc.contributor.author | Ozgocer, Tuba | |
dc.date.accessioned | 2024-08-04T20:43:03Z | |
dc.date.available | 2024-08-04T20:43:03Z | |
dc.date.issued | 2017 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Aim: In recent studies, it has been shown that the Transient Receptor Potential Melastatin-2 Channels (TRPM2) and Phospholipases A2 (PLA(2)) inhibitors may have a protective effect on neurons. This study was aimed to investigate the protective effect of TRPM2 and PLA(2) inhibitor N-(p-amylcinnamoyl) Anthranilic Acid (ACA) in a neurodegenerative model induced by Okadaic Acid (OKA). Main methods: OKA (200 ng/10 mu l) was administered bilateral intracerebroventricularly as a single injection. Key findings: OKA-treated rats showed significant impairments of spatial memory in Morris Water Maze Test. OKA-induced memory-impaired rats showed increased numbers of degenerated neurons and Caspase-3, tau phosphorylated ser396, beta-amyloid positive cells in the hippocampus and cerebral cortex. Furthermore, OKA-treated rats exhibited significantly increased MDA, TNF-alpha levels, and decreased SOD, GSH-PX enzyme activates and GSH levels of the tissues. ACA administration ameliorated OKA-induced memory impairment in rats. The ACA treatment also increased SOD and GSH-PX enzyme activation and GSH levels, and conversely decreased the levels of MDA, TNF-alpha. It was found that the numbers of the degenerated neurons and Caspase-3 positive cells of cortex and hippocampus regions were significantly reduced. Significance: ACA administration attenuates the oxidative stress and neuroinflammation of OKA-induced neurodegeneration; and ameliorates the cognitive decline and neurodegeneration. (C) 2017 Elsevier Inc. All rights reserved. | en_US |
dc.description.sponsorship | Department of Scientific Research Projects of Inonu University [2015/105] | en_US |
dc.description.sponsorship | This study was supported by the Department of Scientific Research Projects of Inonu University (Project no: 2015/105). Competing interests declared. | en_US |
dc.identifier.doi | 10.1016/j.lfs.2017.03.022 | |
dc.identifier.endpage | 20 | en_US |
dc.identifier.issn | 0024-3205 | |
dc.identifier.issn | 1879-0631 | |
dc.identifier.pmid | 28363841 | en_US |
dc.identifier.scopus | 2-s2.0-85016397485 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 10 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.lfs.2017.03.022 | |
dc.identifier.uri | https://hdl.handle.net/11616/97762 | |
dc.identifier.volume | 176 | en_US |
dc.identifier.wos | WOS:000400537500002 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.relation.ispartof | Life Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Okadaic acid | en_US |
dc.subject | N-(p-amylcinnamoyl) anthranilic acid (ACA) | en_US |
dc.subject | Neurodegeneration | en_US |
dc.subject | TRPM2 channel | en_US |
dc.subject | Phospholipases A(2) | en_US |
dc.subject | Alzheimer's disease | en_US |
dc.title | ACA, an inhibitor phospholipases A2 and transient receptor potential melastatin-2 channels, attenuates okadaic acid induced neurodegeneration in rats | en_US |
dc.type | Article | en_US |